BIOPORT CROSSLINK 2.0% Intra-articular Injection - Taiwan Registration cbfaa078304cea82cd2db0a2cf2f2665
Access comprehensive regulatory information for BIOPORT CROSSLINK 2.0% Intra-articular Injection in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number cbfaa078304cea82cd2db0a2cf2f2665 and manufactured by MAXIGEN BIOTECH INC.. The authorized representative in Taiwan is MAXIGEN BIOTECH INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
cbfaa078304cea82cd2db0a2cf2f2665
Ministry of Health Medical Device Manufacturing No. 007515
Product Details
Details are as detailed as approved Chinese instructions
N Orthopedics
N0003 Hyaluronic acid implants for the joint cavity
Produced in Taiwan, China
Dates and Status
Jul 26, 2022
Oct 13, 2026

